Dantrolene Sodium Capsule
NDC Package 64850-842-01
Package Information
Dantrolene Sodium capsules is active hepatic disease, such as hepatitis and cirrhosis, is a contraindication for use of dantrolene sodium capsules. Dantrolene sodium capsules is contraindicated where spasticity is utilized to sustain upright posture and balance in locomotion or whenever spasticity is utilized to obtain or maintain increased function. This formulation utilizes a capsule delivery system. Marketed by Elite Laboratories, Inc., this product is identified by NDC 64850-842 and is authorized under FDA application ANDA076686.
Identification & Billing
- RxCUI: 856652 - dantrolene sodium 100 MG Oral Capsule
- RxCUI: 856656 - dantrolene sodium 25 MG Oral Capsule
- RxCUI: 856660 - dantrolene sodium 50 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64850 - Elite Laboratories, Inc.
- 64850-842 - Dantrolene Sodium
- 64850-842-01 - 100 CAPSULE in 1 BOTTLE
- 64850-842 - Dantrolene Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64850-842-01 identifies a specific commercial package of 100 capsule in 1 bottle of Dantrolene Sodium, a human prescription drug labeled by Elite Laboratories, Inc.. This capsule is formulated for oral use and contains dantrolene sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Elite Laboratories, Inc. on October 26, 2005. The current certification is valid through December 31, 2027.
How is this Elite Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64850084201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.